Clevidipine rapidly and safely reduces blood pressure in acute intracerebral hemorrhage: The ACCELERATE trial

Cerebrovascular Diseases

Volumn 36, Issue 3, 2013, Pages 173-180

  Graffagnino, Carmelo ^a   Bergese, Sergio ^b   Love, James ^c   Schneider, Dietmar ⁱ   Lazaridis, Christos ^d   Lapointe, Marc ^e   Lee, Kiwon ^f   Lynch, Gwendolyn ^g   Hu, Ming Yi ^h   Williams, Gregory C ^h  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c Moses H Cone Hospital   (United States)

^d MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^e MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^f NewYork Presbyterian Hospital   (United States)

^g LERNER RESEARCH INSTITUTE   (United States)

^h MEDICINES COMPANY   (United States)

ⁱ UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Calcium channel blocker; Clevidipine; Hematoma volume; Hypertension; Intracerebral hemorrhage

Indexed keywords

CLEVIDIPINE;

ADULT; ARTICLE; BRAIN HEMATOMA; BRAIN HEMORRHAGE; CLINICAL ARTICLE; CLINICAL EVALUATION; COMPUTER ASSISTED TOMOGRAPHY; CRITICALLY ILL PATIENT; DRUG EFFICACY; DRUG SAFETY; FEMALE; GLASGOW COMA SCALE; HUMAN; HYPERTENSION; HYPOTENSION; MALE; MONOTHERAPY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NEUROLOGIC EXAMINATION; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

ACUTE DISEASE; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; CEREBRAL HEMORRHAGE; FEMALE; GLASGOW COMA SCALE; HUMANS; HYPERTENSION; MALE; PYRIDINES; TREATMENT OUTCOME;

EID: 84886387605     PISSN: 10159770     EISSN: 14219786     Source Type: Journal    
DOI: 10.1159/000351149     Document Type: Article

References (28)

1. Elliott J, Smith M: The acute management of intracerebral hemorrhage: a clinical review. Anesth Analg 2010; 110: 1419-1427.
2. Qureshi AI, Tuhrim S, Broderick JP, Batjer HH, Hondo H, Hanley DF: Spontaneous intracerebral hemorrhage. N Engl J Med 2001; 344: 1450-1460.
3. Broderick J, Connolly S, Feldmann E, Hanley D, Kase C, Krieger D, Mayberg M, Morgenstern L, Ogilvy CS, Vespa P, Zuccarello M: Guidelines for the management of spontaneous intracerebral hemorrhage in adults, 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Stroke 2007; 38: 2001-2023.
4. Steiner T, Bosel J: Options to restrict hematoma expansion after spontaneous intracerebral hemorrhage. Stroke 2010; 41: 402-409.
5. Kazui S, Minematsu K, Yamamoto H, Sawada T, Yamaguchi T: Predisposing factors to enlargement of spontaneous intracerebral hematoma. Stroke 1997; 28: 2370-2375.
6. Mendelow AD, Gregson BA, Fernandes HM, Murray GD, Teasdale GM, Hope DT, Karimi A, Shaw MD, Barer DH, STICH Investigators: Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial. Lancet 2005; 365: 387-397.
7. Adeoye O, Ringer A, Hornung R, Khatri P, Zuccarello M, Kleindorfer D: Trends in surgical management and mortality of intracerebral hemorrhage in the United States before and after the STICH trial. Neurocrit Care 2010; 13: 82-86.
8. Morgenstern LB, Hemphill JC 3rd, Anderson C, Becker K, Broderick JP, Connolly ES Jr, Greenberg SM, Huang JN, MacDonald RL, Messé SR, Mitchell PH, Selim M, Tamargo RJ: Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2010; 41: 2108-2129.
9. Fogelholm R, Avikainen S, Murros K: Prognostic value and determinants of first-day mean arterial pressure in spontaneous supratentorial intracerebral hemorrhage. Stroke 1997; 28: 1396-1400.
10. Anderson CS, Chakera TM, Stewart-Wynne EG, Jamrozik KD: Spectrum of primary intracerebral haemorrhage in Perth, Western Australia, 1989-90: incidence and outcome. J Neurol Neurosurg Psychiatry 1994; 57: 936-940.
11. Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH) Investigators: Antihypertensive treatment of acute cerebral hemorrhage. Crit Care Med 2010; 38: 637-648.
12. Anderson CS, Huang Y, Wang JG, Arima H, Neal B, Peng B, Heeley E, Skulina C, Parsons MW, Kim JS, Tao QL, Li YC, Jiang JD, Tai LW, Zhang JL, Xu E, Cheng Y, Heritier S, Morgenstern LB, Chalmers J, INTERACT Investigators: Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT): a randomised pilot trial. Lancet Neurol 2008; 7: 391-399.
13. Qureshi AI, Palesch YY, Martin R, Novitzke J, Cruz-Flores S, Ehtisham A, Ezzeddine MA, Goldstein JN, Hussein HM, Suri MF, Tariq N, Antihypertensive Treatment of Acute Cerebral Hemorrhage Study Investigators: Effect of systolic blood pressure reduction on hematoma expansion, perihematomal edema, and 3-month outcome among patients with intracerebral hemorrhage: results from the Antihypertensive Treatment of Acute Cerebral Hemorrhage Study. Arch Neurol 2010; 67: 570-576.
14. Anderson CS, Huang Y, Arima H, Heeley E, Skulina C, Parsons MW, Peng B, Li Q, Su S, Tao QL, Li YC, Jiang JD, Tai LW, Zhang JL, Xu E, Cheng Y, Morgenstern LB, Chalmers J, Wang JG, INTERACT Investigators: Effects of early intensive blood pressure-lowering treatment on the growth of hematoma and perihematomal edema in acute intracerebral hemorrhage: the Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT). Stroke 2010; 41: 307-312.
15. Adams HP Jr, del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, Grubb RL, Higashida RT, Jauch EC, Kidwell C, Lyden PD, Morgenstern LB, Qureshi AI, Rosenwasser RH, Scott PA, Wijdicks EF: Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/ American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 2007; 38: 1655-1711, erratum e38, e96.
16. Steiner T, Kaste M, Forsting M, Mendelow D, Kwiecinski H, Szikora I, Juvela S, Marchel A, Chapot R, Cognard C, Unterberg A, Hacke W: Recommendations for the management of intracranial haemorrhage. Part I. Spontaneous intracerebral haemorrhage. The European Stroke Initiative Writing Committee and the Writing Committee for the EUSI Executive Committee. Cerebrovasc Dis 2006; 22: 294-316.
17. Levy JH, Mancao MY, Gitter R, Kereiakes DJ, Grigore AM, Aronson S, Newman MF: Clevidipine effectively and rapidly controls blood pressure preoperatively in cardiac surgery patients: the results of the randomized, placebocontrolled efficacy study of clevidipine assessing its preoperative antihypertensive effect in cardiac surgery-1. Anesth Analg 2007; 105: 918-925.
18. Singla N, Warltier DC, Gandhi SD, Lumb PD, Sladen RN, Aronson S, Newman MF, Corwin HL, ESCAPE-2 Study Group: Treatment of acute postoperative hypertension in cardiac surgery patients: an efficacy study of clevidipine assessing its postoperative antihypertensive effect in cardiac surgery-2 (ESCAPE-2): a randomized, double-blind, placebo-controlled trial. Anesth Analg 2008; 107: 59-67.
19. Pollack CV, Varon J, Garrison NA, Ebrahimi R, Dunbar L, Peacock WF 4th: Clevidipine, an intravenous dihydropyridine calcium channel blocker, is safe and effective for the treatment of patients with acute severe hypertension. Ann Emerg Med 2009; 53: 329-338.
20. Clevipre TM (clevidipine)-prescribing information, revised April 28, 2011. http://www. cleviprex.com/clev-pdfs/1%2014-Proposed-PI-S-003%20(clean%20ver).pdf (accessed February 22, 2012).
21. Kothari RU, Brott T, Broderick JP, Barsan WG, Sauerbeck LR, Zuccarello M, Khoury J: The ABCs of measuring intracerebral hemorrhage volumes. Stroke 1996; 27: 1304-1305.
22. Simon R, Lee YJ: Nonparametric confidence limits for survival probabilities and median survival time. Cancer Treat Rep 1982; 66: 37-42.
23. Nordlander M, Sjöquist PO, Ericsson H, Rydén L: Pharmacodynamic, pharmacokinetic and clinical effects of clevidipine, an ultrashort-acting calcium antagonist for rapid blood pressure control. Cardiovasc Drug Rev 2004; 22: 227-250.
24. Espina IM, Varon J: Clevidipine: a state-ofthe-art antihypertensive drug under the scope. Expert Opin Pharmacother 2012; 13: 387-393.
25. Mayer SA, Kurtz P, Wyman A, Sung GY, Multz AS, Varon J, Granger CB, Kleinschmidt K, Lapointe M, Peacock WF, Katz JN, Gore JM, O'Neil B, Anderson FA, STAT Investigators: Clinical practices, complications, and mortality in neurological patients with acute severe hypertension: the Studying the Treatment of Acute Hypertension registry. Crit Care Med 2011; 39: 2330-2336.
26. Cardene IV (nicardipine HCL)-prescribing information, revised January 2011. http:// www.cardeneiv.com/pdf/40mg-PI.pdf (accessed December 16, 2011).
27. Davis SM, Broderick J, Hennerici M, Brun NC, Diringer MN, Mayer SA, Begtrup K, Steiner T, Recombinant Activated Factor VII Intracerebral Hemorrhage Trial Investigators: Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage. Neurology 2006; 66: 1175-1181.
28. Hu X, Zhang JH, Qin X: Risk factors of early death in patients with hypertensive intracerebral hemorrhage during hospitalization. Acta Neurochir 2011; 111(suppl):387-391.